Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Noosa News21 hours agoWilliam Robinson dies aged 89
-
Noosa News22 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News22 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89
-
General21 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase